The lipoxin biosynthetic circuit and their actions with human neutrophils.

[1]  C. Serhan,et al.  On the relationship between leukotriene and lipoxin production by human neutrophils: evidence for differential metabolism of 15-HETE and 5-HETE. , 1989, Biochimica et biophysica acta.

[2]  J. Lindgren,et al.  Novel transcellular interaction: conversion of granulocyte-derived leukotriene A4 to cysteinyl-containing leukotrienes by human platelets. , 1988, European journal of biochemistry.

[3]  J. White,et al.  The influence of glutathione depleting agents on human platelet function. , 1989, Thrombosis research.

[4]  A. Gilman,et al.  Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin , 1984, Cell.

[5]  C. Serhan.  Lipoxins: Eicosanoids carrying intra-and intercellular messages , 1991, Journal of bioenergetics and biomembranes.

[6]  W. Marasco,et al.  Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors. , 1986, Journal of immunology.

[7]  A. Newby,et al.  Nitroprusside differentially inhibits ADP-stimulated calcium influx and mobilization in human platelets. , 1989, The Biochemical journal.

[8]  B. Samuelsson,et al.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[9]  F. Mollinedo,et al.  Phosphatidylinositol-specific phospholipase D: a pathway for generation of a second messenger. , 1988, Biochemical and biophysical research communications.

[10]  S. Dahlén.  Chapter 10 – Lipoxins: Bioactive Lipoxygenase Interaction Products , 1991 .

[11]  J. Murray,et al.  Release of prostaglandin D2 into human airways during acute antigen challenge. , 1986, The New England journal of medicine.

[12]  T. Strasser,et al.  Differences in arachidonic acid release, metabolism and leukotriene B4 synthesis in human polymorphonuclear leukocytes activated by different stimuli. , 1987, Biochimica et biophysica acta.

[13]  J. Haeggström,et al.  Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human platelet-granulocyte suspensions. , 1988, Biochemical and biophysical research communications.

[14]  A. Marcus,et al.  12S,20-dihydroxyicosatetraenoic acid: a new icosanoid synthesized by neutrophils from 12S-hydroxyicosatetraenoic acid produced by thrombin- or collagen-stimulated platelets. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Stenson,et al.  Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids. , 1979, The Journal of clinical investigation.

[16]  S. Dahlén,et al.  Lipoxin A4 inhibits leukotriene B4-induced inflammation in the hamster cheek pouch. , 1989, Acta physiologica Scandinavica.

[17]  R. Murphy,et al.  Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil. , 1986, The Journal of biological chemistry.

[18]  T. Hugli,et al.  Characterization of leukotriene C4 synthetase in mouse peritoneal exudate cells. , 1988, Biochimica et biophysica acta.

[19]  G. Weissmann,et al.  Endogenous phospholipid metabolism in stimulated neutrophils differential activation by FMLP and PMA. , 1982, Biochemical and biophysical research communications.

[20]  B. Spur,et al.  Lipoxins of the 5-series derived from eicosapentaenoic acid. , 1988, Advances in experimental medicine and biology.

[21]  S. Dahlén,et al.  Lipoxin A. Stereochemistry and biosynthesis. , 1986, The Journal of biological chemistry.

[22]  A. D. de Weck,et al.  Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals , 1988, The Journal of experimental medicine.

[23]  B. Spur,et al.  Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. , 1989, Clinical science.

[24]  G. Weissmann,et al.  Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis. , 1982, Biochemical and biophysical research communications.

[25]  C. Rouzer,et al.  Reversible, calcium-dependent membrane association of human leukocyte 5-lipoxygenase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Smith,et al.  The eicosanoids and their biochemical mechanisms of action. , 1989, The Biochemical journal.

[27]  K. Badr,et al.  Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Snyderman,et al.  Molecular and cellular mechanisms of leukocyte chemotaxis. , 1981, Science.

[29]  C. Serhan,et al.  Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. , 1990, The Journal of clinical investigation.

[30]  P. Ruppel,et al.  Leukotriene B4 binding to human neutrophils. , 1984, Prostaglandins.

[31]  J. Miller,et al.  Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes. , 1986, Molecular pharmacology.

[32]  R. Bryant,et al.  Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. , 1980, The Journal of biological chemistry.

[33]  F. Luscinskas,et al.  Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: Dissociation between lipid remodeling and adhesion , 1990, Journal of cellular physiology.

[34]  S. Dahlén,et al.  Actions of lipoxin A4 and related compounds in smooth muscle preparations and on the microcirculation in vivo. , 1988, Advances in experimental medicine and biology.

[35]  V. Gant,et al.  Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. , 1990, The American review of respiratory disease.

[36]  J. White,et al.  Role of glutathione and glutathione peroxidase in human platelet arachidonic acid metabolism. , 1989, Prostaglandins.

[37]  M. Holtzman,et al.  Heterogeneity of cellular expression of arachidonate 15-lipoxygenase: implications for biological activity. , 1989, Biochimica et biophysica acta.

[38]  B. Samuelsson,et al.  Regulation of the human leukocyte 5-lipoxygenase: stimulation by micromolar Ca2+ levels and phosphatidylcholine vesicles. , 1988, Biochimica et biophysica acta.

[39]  E. Goetzl,et al.  Selective transduction of human polymorphonuclear leukocyte functions by subsets of receptors for leukotriene B4. , 1984, The Journal of allergy and clinical immunology.

[40]  K. Kragballe,et al.  Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE). , 1988, Journal of the American Academy of Dermatology.

[41]  J. Palmblad,et al.  The effects of lipoxin A and lipoxin B on functional responses of human granulocytes. , 1987, Biochemical and biophysical research communications.

[42]  C. Serhan,et al.  Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils , 1990, The Journal of experimental medicine.

[43]  K. Kragballe,et al.  15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4). , 1989, Prostaglandins.

[44]  M. Brezinski,et al.  Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Maclouf,et al.  Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Weissmann,et al.  Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. , 1982, Biochemical and biophysical research communications.

[47]  J. Nishihira,et al.  5-Hydroxyeicosatetraenoate promotes Ca2+ and protein kinase C mobilization in neutrophils. , 1987, Biochemical and biophysical research communications.

[48]  C. Serhan,et al.  Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase. , 1992, Biochimica et biophysica acta.

[49]  M. Brezinski,et al.  Lipoxins stimulate prostacyclin generation by human endothelial cells , 1989, FEBS letters.

[50]  E. Corey,et al.  Receptor-mediated action of hepoxilin A3 releases diacylglycerol and arachidonic acid from human neutrophils. , 1990, Biochemical and biophysical research communications.

[51]  C. Serhan,et al.  Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood. , 1991, Biological mass spectrometry.

[52]  S. Crooke,et al.  Lipoxygenases and Their Products , 1991 .

[53]  L. Dechatelet,et al.  Release and metabolism of arachidonic acid in human neutrophils. , 1981, The Journal of biological chemistry.

[54]  B. Spur,et al.  Lipoxin A4 inhibits phosphoinositide hydrolysis in human neutrophils. , 1990, Biochemical and biophysical research communications.

[55]  J. Haeggström,et al.  Evidence for a 5(6)‐epoxytetraene intermediate in the biosynthesis of lipoxins in human leukocytes , 1986, FEBS letters.

[56]  M. Kawanishi,et al.  Diverse involvements of Ni protein in superoxide anion production in polymorphonuclear leukocytes depending on the type of membrane stimulants. , 1985, Biochemical and biophysical research communications.

[57]  O. Hayaishi.  Advances in Prostaglandin, Thromboxane, and Leukotriene Research , 1985 .

[58]  C. Serhan,et al.  Lipoxins: a new series of eicosanoids (biosynthesis, stereochemistry, and biological activities). , 1988, Advances in experimental medicine and biology.

[59]  G. Weissmann,et al.  Phospholipid metabolism in human neutrophils activated by N-formyl-methionyl-leucyl-phenylalanine. Degranulation is not required for release of arachidonic acid: studies with neutrophils and neutrophil-derived cytoplasts. , 1986, The Biochemical journal.

[60]  L. Mcphail,et al.  Mass determination of receptor-mediated accumulation of phosphatidate and diglycerides in human neutrophils measured by Coomassie blue staining and densitometry. , 1989, Biochemical and biophysical research communications.

[61]  J. Palmblad,et al.  Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[62]  A. A. Spector,et al.  Hydroxyeicosatetraenoic acids (HETEs). , 1988, Progress in lipid research.

[63]  P. Naccache,et al.  Pertussis toxin as a probe of neutrophil activation. , 1986, Federation proceedings.

[64]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[65]  R. Murphy,et al.  Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. A potential cellular source of leukotriene C4. , 1988, The Journal of biological chemistry.

[66]  C. Serhan,et al.  Angioplasty Triggers Intracoronary Leukotrienes and Lipoxin A4: Impact of Aspirin Therapy , 1992, Circulation.

[67]  J. Palmblad,et al.  Formation of lipoxin A by granulocytes from eosinophilic donors , 1987, FEBS letters.

[68]  W. Stenson,et al.  12-L-hydroxy-5,8,10,14-eicosatetraenoic acid, a chemotactic fatty acid, is incorporated into neutrophil phospholipids and triglyceride. , 1979, Prostaglandins.

[69]  C. Serhan,et al.  Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[70]  B. Setty,et al.  15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease. , 1986, The Journal of clinical investigation.

[71]  M. Hamberg,et al.  Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.